Recommendations on multidisciplinary management of elective surgery in people with haemophilia

Haemophilia

Volumn 24, Issue 5, 2018, Pages 693-702

  Escobar, M A ^a   Brewer, A ^b   Caviglia, H ^c   Forsyth, A ^d   Jimenez Yuste, V ^e   Laudenbach, L ^f   Lobet, S ^g   McLaughlin, P ^h   Oyesiku, J O O ⁱ   Rodriguez Merchan, E C ^e   Shapiro, A ^j   Solimeno, L P ^k  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

^c HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^d REBUILD Program Diplomat Specialty Infusion Group   (United States)

^e HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h ROYAL FREE HOSPITAL   (United Kingdom)

ⁱ BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^j INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^k FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

more..

Author keywords

elective surgery; haemophilia; multidisciplinary; physical therapy; planning; recommendations

Indexed keywords

ANALGESIC AGENT; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; MORPHINE; NARCOTIC ANALGESIC AGENT; PARACETAMOL;

COMORBIDITY; CONTINUOUS INFUSION; DENTAL PROCEDURE; ELECTIVE SURGERY; HEMOPHILIA; HEMOPHILIA A; HEMOSTASIS; HUMAN; JOINT DESTRUCTION; LABORATORY TEST; MULTIDISCIPLINARY TEAM; ORTHOPEDIC SURGERY; PEROPERATIVE CARE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REHABILITATION CARE; REVIEW; SYNOVECTOMY; SYNOVITIS; THROMBOSIS PREVENTION; PATHOLOGY; PROCEDURES;

ELECTIVE SURGICAL PROCEDURES; HEMOPHILIA A; HUMANS;

EID: 85053816213     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.13549     Document Type: Review

References (41)

1. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1-e47.
2. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. Blood. 2000;96:437-442.
3. Rodriguez-Merchan EC. Musculo-skeletal manifestations of haemophilia. Blood Rev. 2016;30:401-409.
4. WFH. Factsheet: structure and functions of comprehensive hemophilia treatment centres. 2011. http://elearning.wfh.org/resource/structure-and-functions-of-comprehensive-hemophilia-treatment-centres/. Accessed August 9, 2017.
5. Caviglia H, Narayan P, Forsyth A, et al. Musculoskeletal problems in persons with inhibitors: how do we treat? Haemophilia. 2012;18(Suppl 4):54-60.
6. Escobar M, Maahs J, Hellman E, et al. Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia. 2012;18:971-981.
7. Giangrande PL, Wilde JT, Madan B, et al. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia. 2009;15:501-508.
8. Kulkarni R. Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects. Haemophilia. 2013;19:2-10.
9. Mingot-Castellano ME, Alvarez-Roman MT, Lopez-Fernandez MF, et al. Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors. Eur J Haematol. 2016;96:461-474.
10. ® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery. Haemophilia. 2013;19:294-303.
11. Rodriguez-Merchan EC. Orthopedic surgery is possible in hemophilic patients with inhibitors. Am J Orthop (Belle Mead NJ). 2012;41:570-574.
12. Rodriguez-Merchan EC, Jimenez-Yuste V, Gomez-Cardero P, Alvarez-Roman M, Martin-Salces M, Rodriguez de la Rua A. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience. Haemophilia. 2010;16:84-88.
13. Shapiro A, Cooper DL. U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia. 2012;18:400-405.
14. Solimeno LP, Perfetto OS, Pasta G, Santagostino E. Total joint replacement in patients with inhibitors. Haemophilia. 2006;12(Suppl 3):113-116.
15. Teitel JM, Carcao M, Lillicrap D, et al. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia. 2009;15:227-239.
16. Carcao M, Hilliard P, Escobar MA, Solimeno L, Mahlangu J, Santagostino E. Optimising musculoskeletal care for patients with haemophilia. Eur J Haematol. 2015;95(Suppl 81):11-21.
17. duTreil S. Physical and psychosocial challenges in adult hemophilia patients with inhibitors. J Blood Med. 2014;5:115-122.
18. Morfini M, Benson G, Jimenez-Yuste V, et al. Tailoring care to haemophilia patients’ needs: which specialty and when? Blood Transfus. 2015;13:644-650.
19. Anderson JA, Brewer A, Creagh D, et al. Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J. 2013;215:497-504.
20. Freedman M, Dougall A, White B. An audit of a protocol for the management of patients with hereditary bleeding disorders undergoing dental treatment. J Disabil Oral Health. 2009;10:151-155.
21. Sollecito TP, Abt E, Lockhart PB, et al. The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: evidence-based clinical practice guideline for dental practitioners – a report of the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2015;146:11-16.e8.
22. De Kleijn P, Blamey G, Zourikian N, Dalzell R, Lobet S. Physiotherapy following elective orthopaedic procedures. Haemophilia. 2006;12(Suppl 3):108-112.
23. Forsyth A, Zourikian N. How we treat: considerations for physiotherapy in the patient with haemophilia and inhibitors undergoing elective orthopaedic surgery. Haemophilia. 2012;18:550-553.
24. Jimenez-Yuste V, Rodriguez-Merchan EC, Alvarez MT, Quintana M, Fernandez I, Hernandez-Navarro F. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors. Semin Hematol. 2008;45:S64-S67.
25. Auerswald G, Dolan G, Duffy A, et al. Pain and pain management in haemophilia. Blood Coagul Fibrinolysis. 2016;27:845-854.
26. Stephensen D. Rehabilitation of patients with haemophilia after orthopaedic surgery: a case study. Haemophilia. 2005;11(Suppl 1):26-29.
27. Kwok IH, Paton B, Haddad FS. Does pre-operative physiotherapy improve outcomes in primary total knee arthroplasty? – a systematic review. J Arthroplast. 2015;30:1657-1663.
28. Wang L, Lee M, Zhang Z, Moodie J, Cheng D, Martin J. Does preoperative rehabilitation for patients planning to undergo joint replacement surgery improve outcomes? A systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2016;6:e009857.
29. Shah UJ, Narayanan M, Graham Smith J. Anaesthetic considerations in patients with inherited disorders of coagulation. BJA Educ. 2015;15:26-31.
30. Philipp C. The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology Am Soc Hematol Educ Program. 2010;2010:191-196.
31. Ingerslev J, Hvid I. Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment. Semin Hematol. 2006;43:S23-S26.
32. Negrier C, Shapiro A, Berntorp E, et al. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients. Thromb Haemost. 2008;100:217-223.
33. Escobar MA. Products used to treat haemophilia: dosing. In: Lee CA, Berntorp E, Hoots WK, eds. Textbook of Hemophilia, 3rd edn. Chichester, UK: Wiley-Blackwell; 2014:180-184.
34. Morfini M. The history of clotting factor concentrates pharmacokinetics. J Clin Med. 2017;6:35.
35. Eckhardt CL, van Velzen AS, Peters M, et al. Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood. 2013;122:1954-1962.
36. Buckner TW, Leavitt AD, Ragni M, et al. Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016;116:42-49.
37. Ozelo MC. Surgery in patients with hemophilia: is thromboprophylaxis mandatory? Thromb Res. 2012;130(Suppl 1):S23-S26.
38. Blamey G, Forsyth A, Zourikian N, et al. Comprehensive elements of a physiotherapy exercise programme in haemophilia–a global perspective. Haemophilia. 2010;16(Suppl 5):136-145.
39. De la Corte-Rodriguez H, Rodriguez-Merchan EC. The role of physical medicine and rehabilitation in haemophiliac patients. Blood Coagul Fibrinolysis. 2013;24:1-9.
40. Lobet S, Pendeville E, Dalzell R, et al. The role of physiotherapy after total knee arthroplasty in patients with haemophilia. Haemophilia. 2008;14:989-998.
41. Negrier C, Seuser A, Forsyth A, et al. The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity. Haemophilia. 2013;19:487-498.